Total somatic symptom score as a predictor of health outcome in somatic symptom disorders

British Journal of Psychiatry

Volumn 203, Issue 5, 2013, Pages 373-380

  Tomenson, Barbara ^a   Essau, Cecilia ^b   Jacobi, Frank ^c   Ladwig, Karl Heinz ^d   Leiknes, Kari Ann ^e   Lieb, Roselind ^f   Meinlschmidt, Gunther ^f,g   Mcbeth, John ^h   Rosmalen, Judith ⁱ   Rief, Winfried ^j   Sumathipala, Athula ^k   Creed, Francis ^l  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF ROEHAMPTON   (United Kingdom)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e Norwegian Knowledge Centre for Health Services   (Norway)

^f UNIVERSITY OF BASEL   (Switzerland)

^g RUHR UNIVERSITY BOCHUM   (Germany)

^h KEELE UNIVERSITY   (United Kingdom)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^j PHILIPPS UNIVERSITY MARBURG   (Germany)

^k KING'S COLLEGE LONDON   (United Kingdom)

^l UNIVERSITY OF MANCHESTER   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADJUSTMENT; ADOLESCENT; ADULT; AGED; ANXIETY DISORDER; ARTICLE; CHILD; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DSM-5; DSM-IV; FEMALE; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PREDICTOR VARIABLE; PROBABILITY; PROSPECTIVE STUDY; QUESTIONNAIRE; SCHOOL CHILD; SCORING SYSTEM; SHORT FORM 36; SOMATIZATION; SYMPTOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY; CHILD; CROSS-SECTIONAL STUDIES; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAIN; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SOMATOFORM DISORDERS; YOUNG ADULT;

EID: 84887315781     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.112.114405     Document Type: Article

References (46)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
2. Creed F, Guthrie E, Fink P, Henningsen P, Rief W, Sharpe M, et al. Is there a better term than "medically unexplained symptoms"? J Psychosom Res 2010; 68: 5-8.
3. Dimsdale J, Creed FH. The proposed diagnosis of somatic symptom disorders in DSM-5 to replace somatoform disorders in DSM-IV-a preliminary report. J Psychosom Res 2009; 66: 473-6.
4. Creed F. Should general psychiatry ignore somatization and hypochondriasis? World Psychiatry 2006; 5: 146-50.
5. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64: 258-66.
6. Kisely S, Goldberg D, Simon G. A comparison between somatic symptoms with and without clear organic cause: results of an international study. Psychol Med 1997; 27: 1011-9.
7. Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005; 62: 903-10.
8. Lieb R, Meinlschmidt G, Araya R. Epidemiology of the association between somatoform disorders and anxiety and depressive disorders: An update. Psychosom Med 2007; 69: 860-3.
9. Ladwig KH, Marten-Mittag B, Lacruz ME, Henningsen P, Creed F. Screening for multiple somatic complaints in a population-based survey: does excessive symptom reporting capture the concept of somatic symptom disorders? Findings from the MONICA-KORA Cohort Study. J Psychosom Res 2010; 68: 427-37.
10. Creed FH, Davies I, Jackson J, Littlewood A, Chew-Graham C, Tomenson B, et al. The epidemiology of multiple somatic symptoms. J Psychosom Res 2012; 72: 311-7.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th edn) (DSM-5). APA, 2013.
12. Essau CA. Course and outcome of somatoform disorders in non-referred adolescents. Psychosomatics 2007; 48: 502-9.
13. Lieb R, Zimmermann P, Friis RH, Hofler M, Tholen S, Wittchen HU. The natural course of DSM-IV somatoform disorders and syndromes among adolescents and young adults: A prospective-longitudinal community study. Eur Psychiatry 2002; 17: 321-31.
14. Wittchen H, Perkonigg A, Lachner G, Nelson CB. Early Developmental Stages of Psychopathology Study (EDSP): objectives and design. Eur Addict Res 1998; 4: 18-27.
15. Lieb R, Isensee B, von Sydow K, Wittchen HU. The Early Developmental Stages of Psychopathology Study (EDSP): A methodological update. Eur Addict Res 2000; 6: 170-82.
16. Rief W, Mewes R, Martin A, Glaesmer H, Brä hler E. Evaluating new proposals for the psychiatric classification of patients with multiple somatic symptoms. Psy chosom Med 2011; 73: 760-8.
17. Mewes R, Rief W, Brahler E, Martin A, Glaesmer H. Lower decision threshold for doctor visits as a predictor of health care use in somatoform disorders and in the general population. Gen Hosp Psychiatry 2008; 30: 349-55.
18. Leiknes KA, Finset A, Moum T. Commonalities and differences between the diagnostic groups: current somatoform disorders, anxiety, depression and musculoskeletal disorders. J Psychosom Res 2010; 68: 439-46.
19. Jacobi F, Wittchen H-U, Mü ller N, Hö lting C, Sommer S, Lieb R, et al. Estimating the prevalence of mental and somatic disorders in the community: Aims and methods of the German National Health Interview and Examination Survey. Int J Methods Psychiatr Res 2002; 11: 1-19.
20. Ladwig KH, Marten-Mittag B, Formanek B, Dammann G. Gender differences of symptom reporting and medical health care utilization in the German population. Eur J Epidemiol 2000; 16: 511-8.
21. Rosmalen JGM, Tak LM, de Jonge P. Empirical foundations for the diagnosis of somatization: implications for DSM-5. Psychol Med 2011; 41: 1133-42.
22. Sumathipala A. National Survey on Mental Health in Sri Lanka: Final Research Report. Institute of Research and Development, 2007.
23. Zerssen D. Die Beschwerde-Liste Klinische Selbstbeurteilungsfragebö gen aus dem Mü nchner Psychiatrischen Informationszentrum [List of Clinical Complaints: Self-Rating Questionnaires from the Munich Centre for Psychiatric Research]. Beltz, 1976.
24. Derogatis LR. SCL-90-R: Administration, Scoring, and Procedures Manual for The Revised Version. Johns Hopkins University School of Medicine, 1997.
25. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory. Behav Sci 1974; 19: 1-15.
26. Wittchen H-U. Reliability and validity studies of the WHO Composite International Diagnostic Interview (CIDI): A critical review. J Psychiatr Res 1994; 28: 57-84.
27. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1171-8.
28. Williams A. Euroqol - A new facility for the measurement of health-related quality-of-life. Health Policy 1990; 16: 199-208.
29. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-13.
30. Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder - The GAD-7. Arch Intern Med 2006; 166: 1092-7.
31. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-70.
32. Wittchen H-U, Jacobi F. Size and burden of mental disorders in Europe - A critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15: 357-76.
33. Creed FH, Barsky A. A systematic review of somatisation and hypochondriasis. J Psychosom Res 2004; 56: 391-408.
34. Ü stü n TB, Sartorius N. Mental Illness in General Health Care. An International Study. Wiley, 1996.
35. Katon W, Lin EHB, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007; 29: 147-55.
36. Huijbregts KML, van der Feltz-Cornelis C, van Marwijk HWJ, de Jong FJ, van der Windt DAWM, Beekman ATF. Negative association of concomitant physical symptoms with the course of major depressive disorder: A systematic review. J Psy chosom Res 2010; 68: 511-9.
37. Creed F. The relationship between somatic symptoms, health anxiety, and outcome in medical out-patients. Psychiatr Clin North Am 2011; 34: 545-64.
38. Kisely S, Goldberg D, Simon G. A comparison between somatic symptoms with and without clear organic cause: results of an international study. Psychol Med 1997; 27: 1011-9.
39. Jackson J, Fiddler M, Kapur N, Wells A, Tomenson B, Creed F. Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology, and gastroenterology clinics. J Psychosom Res 2006; 60: 357-63.
40. Kroenke K, Zhong X, Theobald D, Wu JW, Tu WZ, Carpenter JS. Somatic symptoms in patients with cancer experiencing pain or depression prevalence, disability, and health care use. Arch Intern Med 2010; 170: 1686-94.
41. Sogutlu A, Levenson JL, McClish DK, Rosef SD, Smith WR. Somatic symptom burden in adults with sickle cell disease predicts pain, depression, anxiety, health care utilization, and quality of life: The PiSCES Project. Psychosomatics 2011; 52: 272-9.
42. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 2003; 160: 4-12.
43. Mayou R, Kirmayer LJ, Simon G, Kroenke K, Sharpe M. Somatoform disorders: Time for a new approach in DSM-V. Am J Psychiatry 2005; 162: 847-55.
44. Klengel T, Heck A, Pfister H, Brü ckl T, Hennings JM, Menke A, et al. Somatization in major depression - clinical features and genetic associations. Acta Psychiatr Scand 2011; 124: 317-28.
45. Nickel R, Egle UT, Rompe J, Eysel P, Hoffmann SO. Somatisation predicts the outcome of treatment in patients with low back pain. J Bone Joint Surg Br 2002; 84B: 189-95.
46. Creed F, Tomenson B, Guthrie E, Ratcliffe J, Fernandes L, Read N, et al. The relationship between somatisation and outcome in patients with severe irritable bowel syndrome. J Psychosom Res 2008; 64: 613-20.